Xenon Pharmaceuticals Inc (XENE)
Sales/Maturities of Investments
$159.42M
Quarterly · Period ending: · USD
XENE Sales/Maturities of Investments
Latest reported$159.42Mperiod ending
Latest reported$159.42Mperiod ending
XENE Quarterly Sales/Maturities of Investments ($0.00 → $159.42M)
Quarterly Sales/Maturities of Investments
High-resolution chart · PNG
XENE sales/maturities of investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 159,419,000 | |
| 98,503,000 | |
| 337,025,000 | |
| 113,514,000 | |
| 171,233,000 | |
| 165,792,000 | |
| 165,640,000 | |
| 165,176,000 | |
| 237,211,000 | |
| 133,843,000 | |
| 136,940,000 | |
| 195,997,000 | |
| 192,307,000 | |
| 157,110,000 | |
| 102,161,000 | |
| 61,044,000 | |
| 74,543,000 | |
| 20,280,000 | |
| 42,275,000 | |
| 25,799,000 | |
| 30,725,000 | |
| 45,955,000 | |
| 59,364,000 | |
| 53,187,354 | |
| 49,051,652 | |
| 55,204,000 | |
| 4,759,000 | |
| 19,682,000 | |
| 23,374,000 | |
| 27,628,000 | |
| 14,486,000 | |
| 8,890,000 | |
| 11,840,000 | |
| 13,306,000 | |
| 11,592,000 | |
| -75,000 | |
| 31,715,000 | |
| 9,384,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -10,745,000 | |
| 8,927,000 | |
| 243,000 | |
| 1,575,000 | |
| 1,736,000 | |
| 7,235,000 | |
| 1,848,000 | |
| 2,720,000 | |
| 6,550,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |